Cantuaria et al. associated GLUT1 overexpression with poor disease free survival rate in 89 advanced stage ovarian carcinomas [58] while Semaan et al. demonstrated that high GLUT1 expression had a negative impact on the overall survival of 213 ovarian cancer patients [56]. Here, SLC2A1 is linked to ovarian cancer.